SAMBA

 It was created to bridge the gap between scientific personalization
and real-world manufacturing.

While modern medicine can identify highly specific molecular targets,
current production systems are not designed to deliver truly individualized biologics.

SAMBA addresses this limitation by integrating automation,
bioinformatic intelligence and scalable manufacturing principles.
The platform is designed to support N-of-1 and N-of-few therapies
within a controlled, reproducible and sustainable industrial framework.
 
SAMBA does not represent a single therapy,
but a new way to manufacture personalized biologics.
It is the technological foundation behind Tiber Biotech’s AVATAR programs and a key step toward the future of precision immunotherapy.